Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents
Weiteng An(Chinese Academy of Sciences), Jingkang Shen(Shanghai Institute of Materia Medica), Yongliang Zhang(Chinese Academy of Sciences), Tao Meng(Chinese Academy of Sciences), Ting Yu(Chinese Academy of Sciences), Wei Wang(Capital Medical University), Ze‐Hong Miao(Nanchang University)
Cited by 43
Related Papers
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|168
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
|Science Immunology|2020|151